Adenocarcinoma, Prostate
2 clinical trials · Condition
◉ Watch Adenocarcinoma, Prostate
| Record | Firm | Date |
|---|---|---|
| Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients (NCT02987829) | Tracon Pharmaceuticals Inc. | 2017-05-23 |
| Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma (NCT01011751) | Takeda | 2004-04-01 |
Track Adenocarcinoma, Prostate automatically
Every clearance here is in the API, with alerts when new ones post.